Pancreatic cancer is a frequent and lethal disease ranking fourth as a cause of cancer-related death in Western countries.There are patients, though, who respond well to chemotherapy and have a prolonged survival. There is an effort towardsidentification of specific characteristics of these tumor cells in order to identify those patients who will benefit fromchemotherapy and use them as prognostic or predictive factors. This review is an update on the 2013 American Society ofClinical Oncology (ASCO) Annual Meeting regarding the most important developments in this field for pancreatic cancer, asthey were reported in Abstracts #4006, #4016, #4046, and #4060 and a discussion is presented about their application inclinical praxis.
Muhammad Wasif Saif, Konstantinos N Syrigos, Georgios Michael Oikonomopoulos
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : September 18, 2019